Bladder cancer immunotherapy: swinging for the fences

Future Oncol. 2017 Apr;13(9):773-775. doi: 10.2217/fon-2017-0013. Epub 2017 Feb 10.

Authors

Fouad Aoun^{1

2}, Elie El Rassy³, Alexandre Peltier¹

Affiliations

¹ Department of Urology, Jules Bordet Institute, Brussels, Belgium.
² Department of Urology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
³ Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

PMID: 28183191
DOI: 10.2217/fon-2017-0013

No abstract available

Keywords: bladder cancer; clinical trials; immunotherapy.

Publication types

Editorial

MeSH terms

Antineoplastic Agents / immunology
Antineoplastic Agents / therapeutic use*
Drug Approval
Humans
Immunotherapy*
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / immunology
Urinary Bladder Neoplasms / pathology

Substances

Antineoplastic Agents